YD Bio (NASDAQ:YDES) Trading 12.5% Higher – Here’s Why

Shares of YD Bio Limited (NASDAQ:YDES) shot up 12.5% during trading on Tuesday . The company traded as high as $7.45 and last traded at $7.3010. 4,279 shares changed hands during trading, a decline of 88% from the average session volume of 36,567 shares. The stock had previously closed at $6.49.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on YDES shares. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a research report on Monday, December 29th. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, YD Bio currently has a consensus rating of “Sell”.

YD Bio Price Performance

The stock has a 50-day moving average price of $9.59.

Institutional Inflows and Outflows

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC lifted its position in YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent filing with the SEC.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.